Chancity

Personalized Medicine Conference 2026

A conference focused on personalized medicine.

Hyatt Regency Boston/Cambridge

Date
November 18, 2026
Venue
Hyatt Regency Boston/Cambridge
Location
Cambridge, MA

TL;DR

  • The 2026 conference starts November 18 at the Hyatt Regency Boston/Cambridge in Cambridge, Massachusetts.
  • The available event information does not specify ticket pricing or pass inclusions.
  • No attendance total is provided in the available event information.

Who you'll find in the room

Biopharmaceutical innovators

The organizer identifies biopharmaceutical innovators among the conference audience.

Clinicians

The organizer identifies clinicians among the conference audience.

Policymakers

The organizer identifies policymakers among the conference audience.

Patient advocates

The organizer identifies patient advocates among the conference audience.

Technology pioneers

The organizer identifies technology pioneers among the conference audience.

Featured speakers

10 listed

Stacy Cline Amin

Vice President, Chief Counsel for Global Health Regulatory & Policy

Helmy Eltoukhy

Co-Founder, Chairman & Co-Chief Executive Officer

Clifton Leaf

Visiting Member

Former Editor-in-Chief

Peter Marks

Senior Vice President & Head, Infectious Diseases & Molecule Discovery

David Morrow

Scientific Lead for Advanced Therapies

Susanne Munksted

Chief Precision Medicine Officer

George Poste

Regents’ Professor and Del E. Webb Chair in Health Innovation

Daryl Pritchard

Senior Vice President, Science Policy

AmirAli Talasaz

Co-Founder & Co-Chief Executive Officer

Partners on record

16 listed
AACRLabCorpMerckMofoSection 32Slone PartnersApreciaGuardant HealthQuibimTempusAgilentAmgenCarisPfizerLillyPhRMA

Venue & travel

Venue

Hyatt Regency Boston/Cambridge

Questions people ask

5 answered

The conference starts on November 18, 2026.

It takes place at Hyatt Regency Boston/Cambridge in Cambridge, Massachusetts.

The organizer lists biopharmaceutical innovators, clinicians, policymakers, patient advocates, and technology pioneers among the audience.

It is most useful for biopharma, diagnostics and health policy professionals working on precision medicine, since the speakers include Susanne Munksted as Chief Precision Medicine Officer and Daryl Pritchard from science policy, and the sponsors span Pfizer, Merck, Lilly, Guardant Health, Tempus and PhRMA. Bench scientists wanting technical methods sessions would get less, as the audience mix of clinicians, policymakers and patient advocates points to a strategy and policy focus.

Attendees at biopharma and health policy conferences in the Boston area usually wear business casual to business professional, with a blazer common and layers for a November day.

Related events

Find more events with this kind of reach.

We score 300,000+ B2B events by decision-maker density, so you can find the next one for your ICP.

Also listed in